Login to Your Account

Financings Roundup

Arno Advances Cancer Pipeline with $12.7M Private Placement

By Catherine Shaffer
Staff Writer

Wednesday, November 28, 2012
Arno Therapeutics Inc., of Flemington, N.J., closed a $12.7 million private placement of convertible debentures to support research and development of oncology drugs onapristone and AR-42.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription